Triple-negative breast cancer (TNBC) is referred to as a subtype of breast cancer that lacks estrogen receptor (ER), progesterone receptor (PR) expression, and human epidermal growth factor receptor 2 (HER-2) expression/amplification. This evidence concerns the gene ERBB2 and breast cancer.